Written answers

Wednesday, 3 May 2017

Department of Health

Medicinal Products Availability

Photo of Fiona O'LoughlinFiona O'Loughlin (Kildare South, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

19. To ask the Minister for Health if asthma sufferers that have to cease medication during pregnancy can rejoin their medication programme without being penalised in any manner; and if he will make a statement on the matter. [20800/17]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I understand that the medication in question relates to Omalizumab (Xolair), a drug used to treat asthma. The provision of treatment to patients is based on clinical criteria and is a matter for the treating Consultant. Individual patients should consult their GP or treating consultant in relation to their participation in a medication programme.

Comments

No comments

Log in or join to post a public comment.